Nanuk Warman - 21 Oct 2025 Form 4 Insider Report for General Enterprise Ventures, Inc. (GEVI)

Signature
Nanuk Warman
Issuer symbol
GEVI
Transactions as of
21 Oct 2025
Net transactions value
$0
Form type
4
Filing time
21 Oct 2025, 18:27:29 UTC
Previous filing
16 Apr 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Warman Nanuk CFO / Secretary 506 - 3381 CAMBIE ST, VANCOUVER, BRITISH COLUMBIA, CANADA Nanuk Warman 21 Oct 2025 0001381979

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEVI Series C Convertible Preferred Stock Purchase +3,339 +6.7% 53,339 21 Oct 2025 Common Stock 11,130 Sole owner of Nanuk Warman CPA Inc. F1, F2
transaction GEVI Warrant Purchase +5,564 5,564 21 Oct 2025 Common Stock 5,564 $6.00 Sole owner of Nanuk Warman CPA Inc F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series C Convertible Preferred Stock is convertible at any time at the option of the holder into 3.3333 shares of Common Stock. The Series C Convertible Preferred Stock has no expiration date.
F2 On October 21, 2025, the Reporting Person entered into a securities purchase agreement (the "Securities Purchase Agreement") with the Issuer, pursuant to which the Reporting Person purchased 3,339 shares of Series C Convertible Preferred Stock (the "Series C Shares") for an aggregate purchase price of $50,080 ($15.00 per Series C Share).
F3 The Warrant is exercisable at any time by the Reporting Person prior to its expiration, at $6 per share.
F4 In connection with the execution of the Securities Purchase Agreement, the Reporting Person also executed a common stock purchase warrant agreement (the "Warrant Agreement"), pursuant to which the Issuer issued a warrant to the Reporting Person. The Warrant Agreement entitles the Reporting Person to purchase from the Issuer up to 50% of the number of shares of Common Stock issuable upon full conversion of all the Series C Shares purchased by the Reporting Person, subject to the terms and conditions of the Warrant Agreement.